help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gardner, D. G.
Right arrow Articles by Aurbach, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gardner, D. G.
Right arrow Articles by Aurbach, G. D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*INDOMETHACIN
*NAPROXEN
*PARATHYROID HORMONE

Journal of Clinical Endocrinology & Metabolism, Vol 51, 20-25, Copyright © 1980 by Endocrine Society


ARTICLES

Prostaglandin-mediated stimulation of adenosine 3',5'-monophosphate accumulation and parathyroid hormone release in dispersed human parathyroid cells

DG Gardner, EM Brown, MF Attie and GD Aurbach

Freshly dispersed cells were employed to study the effects of various prostaglandins (PGs) on cAMP accumulation and parathyroid hormone release in abnormal human parathyroid tissue. PGE1 and PGE2 effected dramatic increases in intracellular cAMP accumulation over a concentration range of 10(-6)-10(-4) M; the relative effectiveness of these agents varied among different preparations. PGF2 alpha caused a smaller stimulation of cAMP accumulation, and PGF1 alpha was generally without effect. In contrast with the effect previously described in the bovine parathyroid cell system, PGF2 alpha did not suppress agonist- stimulated cAMP accumulation. Both PGE1 and PGE2 enhanced cellular release of parathyroid hormone, with dose-response characteristics similar to those seen with cAMP. In addition, both agents led to a significant stimulation of adenylate cyclase activity in a cellular homogenate preparation. Neither indomethacin (10(-5) M) nor naproxen (10(-4) M) altered the calcium suppressibility of the cells, suggesting that endogenous PG production does not play a major role in the calcium- mediated regulation of parathyroid hormone release.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1980 by The Endocrine Society